Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis

Arthritis and Rheumatism

Volumn 41, Issue 5, 1998, Pages 910-917

  Leech, Michelle ^a   Metz, Christine ^b   Santos, Leilani ^a   Peng, Tina ^b   Holdsworth, Stephen R ^a   Bucala, Richard ^b   Morand, Eric F ^a  

^a MONASH MEDICAL CENTRE   (Australia)

^b PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EVOLUTION; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ANTIBODIES, MONOCLONAL; ARTHRITIS, EXPERIMENTAL; BLOTTING, WESTERN; CELL COUNT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EDEMA; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MALE; NEUTRALIZATION TESTS; RATS; RATS, SPRAGUE-DAWLEY; SYNOVIAL MEMBRANE;

EID: 0031969436     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199805)41:5<910::AID-ART19>3.0.CO;2-E     Document Type: Article

References (33)

1. David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Pathology 1966;56:72-7.
2. Nathan CF, Karnovsky ML, David JR. Alterations of macrophage functions by mediators from lymphocytes. J Exp Med 1971;133: 1356-76.
3. Bloom BR, Bennet B. Mechanism of a reaction in vitro associated with delayed type hypersensitivity. Science 1966;153:80-2.
4. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R. Purification, bioactivity and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 1994;33:14144-55.
5. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macropage migration inhibitory factor. J Exp Med 1994;179:1895-902.
6. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
7. Bacher M, Metz CN, Calandra T, Mayer K, Cheney J, Lohoff M, et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A 1996;93:7489-854.
8. Klareskog L. What can we learn about arthritis from animal models? Springer Semin Immunopathol 1989;11:315-33.
9. Taurog JD, Sandberg GP, Mahowald ML. The cellular basis of adjuvant arthritis. II. Characterization of the cells mediating passive transfer. Cell Immunol 1983;80:198-204.
10. Billingham MEJ, Hicks C, Carney S. Monoclonal antibodies and arthritis. Agents Actions 1990;29:77-87.
11. Santos LL, Morand EF, Yang YH, Hutchinson P, Holdsworth SR. Suppression of adjuvant arthritis and synovial macrophage inducible nitric oxide by N-iminoethyl-L-ornithine, a nitric oxide synthase inhibitor. Inflammation 1997;21:299-311.
12. 2 MDP liposomes. Rheumatol Int 1994;13:221-8.
13. Santos LL, Morand EF, Hutchinson P, Boyce NW, Holdsworth SR. Anti-neutrophil monoclonal antibody therapy inhibits the development of adjuvant arthritis. Clin Exp Immunol 1997;107: 248-54.
14. Lan HY, Mu W, Yang NS, Meinhardt A, Nikolic-Paterson DJ, Ng YY, et al. De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol 1996;149:1119-27.
15. Pellegri C, Franch A, Castellote C, Castell M. Immunohistochemical changes in synovial tissue during the course of adjuvant arthritis. J Rheumatol 1995;22:124-32.
16. Bacher M, Meinhardt A, Lan HY, Mu W, Metz CN, Chesney JA, et al. Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol 1997;150:235-46.
17. Nathan CF, Remold HG, David JR. Characterization of a lymphocyte factor which alters macrophage functions. J Exp Med 1973;137:275-89.
18. Churchill WH, Piessens WF, Sulis CA, David JR. Macrophages activated as suspension cultures with lymphocyte mediators devoid of antigen become cytotoxic for tumor cells. J Immunol 1975;115: 781-6.
19. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donelly T, et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71.
20. Bernhagen J, Bacher M, Calandra T, Metz CN, Doty SB, Donelly T, et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity response. J Exp Med 1996;183:277-82.
21. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, et al. MIF is a pituitary derived cytokine that potentiates lethal endotoxemia. Nature 1993;365:756-9.
22. Lan HY, Bacher M, Yang N, Mu W, Nikolic-Paterson DJ, Metz C, et al. The pathogenic role of MIF in immunologically-induced kidney disease in the rat. J Exp Med 1997;185:1455.
23. Van Eden W, Holoshitz J, Nevo Z, Frenkel A, Klajman A, Cohen IR. Arthritis induced by a T-lymphocyte clone that responds to Mycobacterium tuberculosis and to cartilage proteoglycans. Proc Natl Acad Sci U S A 1985;82:5117-20.
24. Van Lent PLEM, Holthuysen AEM, van den Bersselaar L, van Rooijen N, van de Putte LBA, van den Berg WB. Role of macrophage-like synovial lining cells in localisation and expression of experimental arthritis. Scand J Rheumatol 1995;24 Suppl 101:83-9.
25. Meyersiegler K, Hudson PB. Enhanced expression of macrophage migration inhibitory factor in prostatic adenocarcinoma metastases. Urology 1996;48:448-52.
26. Firestein GS, Zvaifler NJ. The role of T cells in rheumatoid arthritis [letter]. Ann Rheum Dis 1993;52:765.
27. Zvaifler NJ, Firestein GS. Pannus and pannocytes: alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 1994;37:783-9.
28. Sarlis NJ, Chowdrey HS, Stephanou A, Lightman SL. Activation of the hypothalamo-pituitary-adrenal axis and loss of diurnal rhythmicity during adjuvant induced arthritis in the rat. Endocrinology 1992;130:1775-9.
29. Nishino T, Bernhagen J, Shiiki H, Calandra T, Dohi K, Bucala R. Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland. Mol Med 1995;1:781-8.
30. Yang YH, Hutchinson P, Leech M, Morand EF. Exacerbation of adjuvant arthritis by adrenalectomy is associated with reduced leukocyte lipocortin 1. J Rheumatol 1997;24:1758-64.
31. Donelly SC, Haslett C, Reid PT, Grant IS, Wallace WP, Metz CN, et al. MIF in human lung disease. Nat Med 1997;3:320-3.
32. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 1992;89:9784-8.
33. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 1993;36:1681-90.